We estimate that the CEO of Oscar Health, Inc. ($OSCR), Mark T. Bertolini, received a compensation of $1,149,308 in 2025. This is an increase of 20.39% from an estimated $915,000 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 22, 2026. Note that parsing errors may occur.
You can track $OSCR on Quiver Quantitative's $OSCR stock dashboard.
$OSCR Stock Insider Trading Activity
$OSCR Stock insiders have traded $OSCR stock on the open market 18 times in the past 6 months. Of those trades, 1 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $OSCR stock by insiders over the last 6 months:
- MARIO SCHLOSSER (President of Technology & CTO) has made 0 purchases and 9 sales selling 813,478 shares for an estimated $12,564,166.
- MARK T BERTOLINI (Chief Executive Officer) purchased 1,000,000 shares for an estimated $11,920,000
- RICHARD SCOTT BLACKLEY (Chief Financial Officer) has made 0 purchases and 2 sales selling 44,356 shares for an estimated $674,358.
- ADAM MCANANEY (Chief Legal Officer) has made 0 purchases and 2 sales selling 20,562 shares for an estimated $281,251.
- JANET LIANG (President, Oscar Insurance) has made 0 purchases and 2 sales selling 14,791 shares for an estimated $221,533.
- VICTORIA BALTRUS (Chief Accounting Officer) has made 0 purchases and 2 sales selling 8,787 shares for an estimated $130,934.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OSCR Stock Hedge Fund Activity
We have seen 167 institutional investors add shares of $OSCR Stock stock to their portfolio, and 174 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 5,422,772 shares (-65.3%) from their portfolio in Q4 2025, for an estimated $77,925,233
- BIT CAPITAL GMBH added 5,227,152 shares (+545.0%) to their portfolio in Q4 2025, for an estimated $75,114,174
- D. E. SHAW & CO., INC. added 4,500,503 shares (+283.6%) to their portfolio in Q4 2025, for an estimated $64,672,228
- JANE STREET GROUP, LLC added 4,012,871 shares (+226.8%) to their portfolio in Q4 2025, for an estimated $57,664,956
- TWO SIGMA INVESTMENTS, LP added 3,924,897 shares (+1415.2%) to their portfolio in Q4 2025, for an estimated $56,400,769
- CAPITAL WORLD INVESTORS removed 3,622,586 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $52,056,560
- FARALLON CAPITAL MANAGEMENT LLC removed 3,375,000 shares (-92.7%) from their portfolio in Q4 2025, for an estimated $48,498,750
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OSCR Stock Analyst Ratings
Wall Street analysts have issued reports on $OSCR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/26/2025
- Wells Fargo issued a "Underweight" rating on 11/13/2025
- Barclays issued a "Underweight" rating on 11/10/2025
- UBS issued a "Sell" rating on 11/07/2025
To track analyst ratings and price targets for $OSCR Stock, check out Quiver Quantitative's $OSCR forecast page.
$OSCR Stock Price Targets
Multiple analysts have issued price targets for $OSCR recently. We have seen 6 analysts offer price targets for $OSCR in the last 6 months, with a median target of $17.0.
Here are some recent targets:
- David Windley from Jefferies set a target price of $16.0 on 04/20/2026
- Jonathan Yong from UBS set a target price of $17.0 on 01/09/2026
- Andrew Mok from Barclays set a target price of $18.0 on 01/05/2026
- Dean Sublett from Stephens & Co. set a target price of $17.0 on 12/11/2025
- Jessica Tassan from Piper Sandler set a target price of $25.0 on 11/26/2025
- Stephen Baxter from Wells Fargo set a target price of $11.0 on 11/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
